Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk

被引：47

作者：

Baxter, SW ^{[1
]}

Campbell, IG ^{[1
]}

机构：

[1] Peter MacCallum Canc Inst, Victorian Breast Canc Res Consortium, Canc Genet Lab, E Melbourne, Vic 8006, Australia

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 07期

关键词：

D O I：

10.1093/jnci/93.7.557

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：557 / 558

页数：2

相关论文

共 7 条

[1] Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk
Ameyaw, MM
Thornton, N
McLeod, HL
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23) : 1947 - 1947
[2] Aunoble B, 2000, INT J ONCOL, V16, P567
[3] Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy
Gregory, RK
Powles, TJ
Salter, J
Chang, JC
Ashley, S
Dowsett, M
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (02) : 171 - 175
[4] G-POLYMORPHISM TO A-POLYMORPHISM AT AMINO-ACID CODON 655 OF THE HUMAN ERBB-2/HER2 GENE
PAPEWALIS, J
NIKITIN, AY
RAJEWSKY, MF
[J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (19) : 5452 - 5452
[5] The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells
Pegram, MD
Finn, RS
Arzoo, K
Beryt, M
Pietras, RJ
Slamon, DJ
[J]. ONCOGENE, 1997, 15 (05) : 537 - 547
[6] HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE
SLAMON, DJ
CLARK, GM
WONG, SG
LEVIN, WJ
ULLRICH, A
MCGUIRE, WL
[J]. SCIENCE, 1987, 235 (4785) : 177 - 182
[7] Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk
Xie, DW
Shu, XO
Deng, ZL
Wen, WQ
Creek, KE
Dai, Q
Gao, YT
Jin, F
Zheng, W
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (05) : 412 - 417